CA2378987C - Liant pour compositions pharmaceutiques - Google Patents

Liant pour compositions pharmaceutiques Download PDF

Info

Publication number
CA2378987C
CA2378987C CA002378987A CA2378987A CA2378987C CA 2378987 C CA2378987 C CA 2378987C CA 002378987 A CA002378987 A CA 002378987A CA 2378987 A CA2378987 A CA 2378987A CA 2378987 C CA2378987 C CA 2378987C
Authority
CA
Canada
Prior art keywords
binder
pharmaceutical composition
active ingredient
echinacea extract
echinacea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002378987A
Other languages
English (en)
Other versions
CA2378987A1 (fr
Inventor
Sigal First
Rina Yamin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CTS Chemical Industries Ltd
Original Assignee
CTS Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CTS Chemical Industries Ltd filed Critical CTS Chemical Industries Ltd
Publication of CA2378987A1 publication Critical patent/CA2378987A1/fr
Application granted granted Critical
Publication of CA2378987C publication Critical patent/CA2378987C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques, contenant un liant qui comprend une quantité de préparation de <i>Echinacea</i> efficace pour effectuer une liaison.
CA002378987A 1999-08-09 2000-07-13 Liant pour compositions pharmaceutiques Expired - Fee Related CA2378987C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL131317 1999-08-09
IL131317A IL131317A (en) 1999-08-09 1999-08-09 Binder for pharmaceutical compositions
PCT/IL2000/000412 WO2001010415A1 (fr) 1999-08-09 2000-07-13 Liant pour compositions pharmaceutiques

Publications (2)

Publication Number Publication Date
CA2378987A1 CA2378987A1 (fr) 2001-02-15
CA2378987C true CA2378987C (fr) 2008-05-06

Family

ID=11073130

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002378987A Expired - Fee Related CA2378987C (fr) 1999-08-09 2000-07-13 Liant pour compositions pharmaceutiques

Country Status (5)

Country Link
EP (1) EP1200069A1 (fr)
AU (1) AU5842800A (fr)
CA (1) CA2378987C (fr)
IL (1) IL131317A (fr)
WO (1) WO2001010415A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN192160B (fr) * 2000-07-17 2004-02-28 Ranbaxy Lab

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT385654B (de) * 1984-09-04 1988-05-10 Arcana Chem Pharm Verfahren zur herstellung von oelhaeltigen zubereitungen in granulatform zur oralen verabreichung
DK0620727T3 (fr) * 1992-01-17 1997-05-26 Alfatec Pharma Gmbh
ATE204159T1 (de) * 1995-05-17 2001-09-15 Peter Greither Verfahren zum herstellen eines brausepräparats und brausepräparat

Also Published As

Publication number Publication date
AU5842800A (en) 2001-03-05
EP1200069A1 (fr) 2002-05-02
CA2378987A1 (fr) 2001-02-15
IL131317A0 (en) 2001-01-28
IL131317A (en) 2006-08-01
WO2001010415B1 (fr) 2001-08-16
WO2001010415A1 (fr) 2001-02-15

Similar Documents

Publication Publication Date Title
JP3647897B2 (ja) 徐放性単位剤形
KR0166064B1 (ko) 회전 과립화 및 맛 은폐용 피막의 형성에 의한 저작성 약제학적 정제의 제조방법
JP3045924B2 (ja) 放出が調整された経口薬剤調合物
AU760006B2 (en) Method for making granules with masked taste and instant release of the active particle
KR960005706B1 (ko) 경구용 서방성 아세트아미노펜 제형 및 이의 제조방법
CA2888278A1 (fr) Formulations de medicament pour administration par voie orale
WO1999016448A1 (fr) Comprime de theophylline a liberation prolongee
JP2007530684A (ja) 吸着剤と逆作用薬とを含有する不正使用防止投与剤型
JP2009528329A (ja) 事故的誤用および不法転用を防止するための耐破砕性錠剤
TWI374035B (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
JP2001172201A (ja) 経口投与形のための味をマスキングするコーティングとしてのフィルム被覆の使用、経口投与形及びその製造法
JPH05200099A (ja) 活性成分を含有する予め成形された微小粒子より製造される機械的に安定でかつ容易に分解し得る錠剤
KR100369874B1 (ko) 제산제조성물및약제조성물
CN108201534A (zh) 一种瑞卡帕布口服缓控释药物组合物及其用途
WO2013082706A1 (fr) Formulation de doxylamine et de pyridoxine à libération prolongée sans délitant et procédé de fabrication associé
JP4856843B2 (ja) 新規フェノフィブラート錠剤
JP2007055924A (ja) イブプロフェン及び塩酸アンブロキソール含有固形製剤
CN108201535A (zh) 一种维利帕尼缓控释药物组合物及其用途
JP5347092B2 (ja) アンドログラフィス抽出物製剤
CA2378987C (fr) Liant pour compositions pharmaceutiques
KR101168189B1 (ko) 불쾌미를 개선한 피복 제제의 제조 방법
JPH08310969A (ja) 固形薬品組成物及びその製造方法
JP2013023463A (ja) 生理活性物質含有粒子の製造方法
CN101385733B (zh) 一种复方甘草酸苷缓释制剂
CN105407876A (zh) 包含异烟肼颗粒和利福喷汀颗粒的呈可分散的片剂形式的抗结核病的稳定的药物组合物及其制备方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed